Conference Highlights — May 11, 2026

Opening Ceremony

The conference officially opened with welcome remarks from Anas Jawed, CEO of Next Business Media, who welcomed attendees, speakers, and partners from across the world. In his address, he emphasized the growing importance of collaboration, innovation, and leadership in shaping the future of the pharmaceutical and biotechnology industries.

Keynote & Speaker Session Highlights

Throughout the day, attendees experienced a series of insightful keynote presentations, expert-led sessions, and strategic panel discussions addressing the evolving landscape of global healthcare and life sciences.

Learning Chemistry Beyond Rules: From Fragments to Drug-like Molecules with Generative AI

Lisa Piazza from the University of Pisa explored how generative AI is transforming medicinal chemistry by enabling the creation of novel drug-like molecules. The session highlighted the growing role of AI in accelerating pharmaceutical research and early-stage drug discovery.

Clinical Trials & Case Studies

Alfonso García Cañamaque shared valuable insights from clinical research projects, discussing challenges, best practices, and opportunities for innovation. The session emphasized the importance of data-driven approaches in improving clinical trial outcomes.

AI Compliance Master-Class in Pharma: Mapping the Intersection of Laws, Standards, and Governance

Nikodem Latocha examined the evolving regulatory landscape surrounding artificial intelligence in healthcare. Attendees gained practical insights into compliance, governance frameworks, and responsible AI adoption within pharmaceutical organizations.

SILCS: Combining Physics-Based Data and AI for Drug Design and Development

Dr. Alexander MacKerell demonstrated how physics-based modeling combined with AI can enhance drug discovery and development. The presentation showcased innovative approaches to improving accuracy and efficiency in pharmaceutical research.

From Alpha to Omega: AI-Powered Advanced 3D Cellular Models in Drug Discovery

Alessandro Scandurra presented how advanced 3D cellular models powered by AI are helping researchers better understand disease mechanisms and accelerate therapeutic development. The session highlighted the future of predictive drug testing.

The Future of Pharma: Expert Insights

Industry experts discussed the key trends shaping the future of pharmaceuticals, including AI adoption, digital transformation, innovation strategies, and patient-centered healthcare. The panel provided diverse perspectives on the opportunities ahead for the industry.

Innovating Pharma Supply Chains: From AI-Driven Strategy to Global Distribution

This panel explored how artificial intelligence and advanced analytics are helping pharmaceutical companies improve supply chain resilience, efficiency, and decision-making. Speakers also addressed challenges related to global distribution and operational agility.

How Social Media Listening Combined with AI is Revolutionizing the Pharma and Medical World

Francisco Javier Domingo highlighted how AI-powered social media analytics can help organizations better understand patient sentiment, market trends, and stakeholder engagement. The session demonstrated the growing value of digital intelligence in healthcare.

Innovation vs. Necessity: Is Digitalization Always the Answer in Clinical Research?

Dr. Marek Wasiluk challenged attendees to critically evaluate digital transformation initiatives within clinical research. The presentation emphasized balancing technological innovation with practical value and patient needs.

Beyond the Pill: Scaling AI in Drug Discovery, MedTech and Commercial Excellence

Alejandro Villaveces explored how AI is driving innovation across multiple areas of healthcare, from research and development to commercial operations. The session showcased practical examples of AI delivering measurable business and clinical impact.

Next Generation RWE (AI & Living Evidence Hubs, The New Generation of RWE)

Dr. Ignacio H. Medrano presented emerging approaches to real-world evidence generation using AI and living evidence ecosystems. The session highlighted how data-driven insights can improve healthcare decision-making and patient outcomes.

Stability Studies in Brazil (Zone IVB) of Medicines and Food Supplements

Ana Augusta Lemos shared expertise on stability testing requirements for pharmaceutical products and food supplements in Brazil’s climatic Zone IVB. The session provided valuable regulatory and quality assurance insights for global manufacturers.

Protecting Pollinators: The Overlooked Pillar of Global Food Security and One Health

Miguel Angel Rodriguez discussed the critical role pollinators play in sustaining food systems, biodiversity, and public health. The presentation connected environmental sustainability with broader One Health objectives.

Industry Discussions & Networking

Throughout the event, attendees participated in engaging discussions on topics including:

• The future of biotech innovation
• AI in pharmaceutical commercialization
• Patient access and equitable healthcare
• Digital transformation in pharma
• Commercial strategy and market access
• Rare diseases and oncology advancements
• Sustainable healthcare systems
• Leadership in global pharma organizations

The networking sessions provided valuable opportunities for executives, innovators, researchers, and healthcare leaders to connect, exchange ideas, and explore future collaborations.